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Abstract
Higher eukaryotes have developed extensive compartmentalization of amino acid (aa) - tRNA 
coupling through the formation of a multi-synthetase complex (MSC) that is composed of eight 
aa-tRNA synthetases (ARS) and three scaffold proteins: aminoacyl tRNA synthetase complex 
interacting multifunctional proteins (AIMP1, 2 and 3). Lower eukaryotes have a much smaller 
complex while yeast MSC consists of only two ARS (MetRS and GluRS) and one ARS cofactor 1 
protein, Arc1p (1), the homolog of the mammalian AIMP1. Arc1p is reported to form a tripartite 
complex with GluRS and MetRS through association of the N-terminus GST-like domains (GST-
L) of the three proteins (2). Mammalian AIMP1 has no GST-L domain corresponding to Arc1p N-
terminus. Instead, AIMP3, another scaffold protein of 18 kDa composed entirely of a GST-L 
domain, interacts with Methionyl-tRNA synthetase (MARS)(3) and Glutamyl-Prolyl-tRNA 
Synthetase (EPRS)(4). Here we report two new interactions between MSC members: AIMP1 
binds to EPRS and AIMP1 binds to AIMP3. Interestingly, the interaction between AIMP1 and 
AIMP3 complex makes it the functional equivalent of a single Arc1p polypeptide in yeast. This 
interaction is not mapped to AIMP1 N-terminal coiled-coil domain, but rather requires an intact 
tertiary structure of the entire protein. Since AIMP1 also interacts with AIMP2, all three proteins 
appear to compose a core docking structure for the eight ARS in the MSC complex.
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INTRODUCTION
Protein translation efficiency depends on many aspects, including how quickly transfer 
RNAs can be recharged and localize toward ribosomes undergoing elongation of peptides. 
Depending on cellular demands and the organism, the supply and assembly of aminoacyl-
tRNA synthetases into a multi-synthetase complex (MSC) varies. For example, in yeast, 
MSC is simplified containing a scaffold protein, Arc1p, methionyl-tRNA synthetase 
(MetRS) and glutamyl tRNA synthetase (GluRS). Compared to yeast, mammalian cells 
feature additional proteins within the MSC complex: 3 scaffold proteins named aminoacyl 
tRNA Synthetase Complex Interacting Multifunctional Protein 1–3 interacting with 9 
aminoacyl-tRNA synthetases. The hypothesized ability of aminoacyl tRNA synthetase 
family members to adjust aminoacyl-tRNA coupling to the rate of cellular metabolic needs 
may explain their “moonlighting” functions (5).
In yeast, Arc1p (mammalian homolog, AIMP1) tightly associates with two cytosolic 
enzymes, MetRS and GluRS. The simplicity of the single Arc1p scaffold with the two 
enzymes has distinct growth advantages. For example, genetic disruption of Arc1p reduced 
MetRS activity while slowing growth, therefore imparting a survival advantage in a range of 
temperatures, between 15 and 23 degrees Celsius (1). In fact, it appears that the two 
enzymes within the Arc1p complex might not be a random choice. Without enzymes to 
metabolize specifically glutamine, yeast utilizes glutamate as their substrate. Yeast with 
methionine restriction paired with elevated glutamic acid was reported to contribute to its 
longevity, independent of glucose. Importantly, aside from glutamic acid, availability of any 
other non-essential amino acid had no such effect (6).
Arc1p is made up of three domains: (1) an N-terminus GST-L domain; (2) unstructured; (3) 
tRNA binding domain (TRBD). The first domain is sufficient for the MetRS and GluRS 
binding followed by an undefined unstructured middle region and finally the TRBD which 
binds to tRNA (7). In yeast, the primary function for the Arc1P-GluRS-MetRS complex is 
the synchronization of nuclear transcription and mitochondrial translation of ATP synthetase 
genes (8). In contrast to yeast, mammalian cells contain a splitting of the GST-L domains 
from the TRBD domain. Within mammalian MSC, AIMP2 and AIMP3, two of the 3 
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scaffold proteins mentioned above, both contain GST-L binding domains. However, AIMP1, 
the third scaffold protein, has no GST-like domain. Instead, it contains approximately a 70 
amino acid (a.a.) long coiled-coil domain, followed by an unstructured region and TRBD 
domains (9). The AIMP1 coiled-coil domain is further subdivided into two regions; an N 
terminal part that interacts with the coiled-coil domain of AIMP2 and the distal part that 
interacts with RARS. The remainder of AIMP1, (also known as p43), retains 54% identity to 
the Arc1p protein (by NCBI-BLAST).
Interestingly, at least 4 of the ARS enzymes within this complex and all 3 scaffold proteins 
have secondary, moonlighting functions (5). AIMP1 is one such protein, as it is reported to 
undergo cleavage, and the C-terminal fragment (AIMP1: a.a. 146-312), was identified as 
extracellular Endothelial Monocyte-Activating Peptide II (EMAP II) – an anti-angiogenic 
protein and positive mediator of macrophage migration (10–12) (13). Dissociation of one 
MSC protein may affect the release of its interacting partners as well; therefore, the 
physiological effect of the MSC should be considered. Our studies determined that full-
length AIMP1 binds to AIMP3. Furthermore, the N-terminus of AIMP1 is also a binding 
partner with the GST-L domain of EPRS (Glutamyl-Prolyl-tRNA Synthetase). Binding of 
AIMP1 to AIMP3, or its known binding partner AIMP2, could participate in EPRS binding. 
Our studies support AIMP1, while linking the other two scaffold proteins, as the only 
scaffold protein to bind all four components of the GST-tetrameric complex suggesting that 
AIMP1, the only TRBD protein, may function as a docking site for tRNA and GST-L 
domain proteins of the MSC complex.
RESULTS
AIMP1 binds to the GST-like domain of the ARS protein EPRS (Glutamyl-Prolyl-tRNA 
Synthetase)
To assess interactions of the full length AIMP1 protein, an AIMP1-EGFP fusion construct 
was transiently expressed in HEK293 cell line and pulled down with anti-EGFP antibodies. 
Samples resolved on an SDS-PAGE gel followed by silver staining, revealed co-
immunoprecipitation (co-IP) of a prominent 175 kDa band, with additional less pronounced 
smaller size proteins and no clear resolving proteins smaller than 35 kDa (Fig. 1A). 
MALDI-TOF mass-spectroscopy identified the unique peptides of the 175 kDa protein as 
EPRS (Table 1). Cells co-transfected with AIMP1 full length (a.a. 1-312) and truncated (t) 
EPRS (a.a. 1-970t) confirmed binding of AIMP1 to EPRS using co-IP (Fig. 1B). Deletion 
constructs of AIMP1 identified the N-terminus of AIMP1 binds to and is necessary to bind 
to EPRS 1-907t as the AIMP1 C-Terminus (a.a. 146-312) deletion construct did not 
immunoprecipitate with EPRS 1-970t (Fig. 1B).
EPRS consists primarily of four domains: (1) GST-L (a.a. 51-162); (2) Glu-ARS (a.a. 
425-502); (3) 3 consecutive WHEP elements (a.a. 749-810, 822-888, and 900-966); (4) and 
Pro-ARS (a.a. 1023-1296). To identify the region of EPRS that AIMP1 interacts with, 
deletion mutants of EPRS were co-transfected with full length AIMP1 (a.a. 1-312). Deletion 
of the EPRS C-terminal domains Glu-ARS, WHEP, and Pro-ARS had no effect on 
AIMP1:EPRS binding, suggesting that AIMP1 binds to the N-terminus of EPRS (a.a. 
1-200). (Fig 1D). Further deletion analysis identified the GST-L domain of EPRS was 
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sufficient for co-IP with endogenous AIMP1 (Fig. 1E) confirming an independent report on 
GST-L domains within the MSC as one of the two main protein-protein interaction domains 
(4).
Binding of full-length AIMP1 to AIMP2 participates in AIMP1-EPRS binding
Based on the previously documented multitude of interactions within the MSC (14), EPRS is 
likely to be recruited to AIMP1 indirectly, through binding of other components of the MSC 
complex. The other common protein-protein interaction module in MSC is the coiled-coil 
domain, such as N-terminal 1 to 70 a.a. region of AIMP1. As GST-L domains exhibit 
homotypical interactions, AIMP2 was identified as a possible facilitator for AIMP1-EPRS 
interaction as AIMP2 contains both a coiled-coil and GST-L domain, while AIMP3 is 
composed entirely of a GST-L domain making it less likely to mediate this reaction.
The EPRS GST-L domain forms complexes with AIMP3 and AIMP2 (4). Previous studies 
suggest that AIMP2 can reportedly bridge EPRS and AIMP1 through an interaction with the 
coiled-coil domain of AIMP1 (15). As the amount of endogenous AIMP2 seems to be the 
limiting factor for this association, we were able to bind AIMP1:EPRS co-IP by co-
expressing HA-tagged AIMP2 (Fig. 2A). In addition, previous studies have shown that 
EPRS binds to AIMP2 and AIMP3 (4). To differentiate whether the EPRS pull-down by 
AIMP1 was mediated solely by coiled-coil domain interactions, we tested GST-L pull-down 
using full-length AIMP1 or the AIMP1 N-terminal coiled-coil domain alone. Full-length and 
AIMP1 N-terminal coiled-coil domain of AIMP1 protein pulls down endogenous EPRS. 
(Fig. 2B).
The full-length of AIMP1 binds AIMP3
AIMP1-AIMP2 interaction maps to the 1-70 a.a. coiled-coil region (15). We tested whether 
the AIMP3 scaffold protein could be a contributing factor by interacting with AIMP1 
outside of its coiled-coil domain. First, we tested co-IP of AIMP3 with full length of AIMP1 
(a.a. 1-312) or AIMP1’s coiled-coil domain (a.a. 1-70) alone. Endogenous AIMP3 and 
EPRS immunoprecipitated with full-length AIMP1 protein and AIMP1’s coiled-coil domain 
(Fig. 2B). However, unlike AIMP2, AIMP3 is found abundantly in cells and it seems to be 
stable even when it is not in complex within MSC (4). In order to test the AIMP1-AIMP3 
interaction while excluding the contribution of other proteins, we performed an in vitro test 
using recombinant proteins (Fig. 2C) to determine direct AIMP1 to AIMP3 binding. AIMP3 
was found to interact with full-length AIMP1 (Fig. 2D). Previously, AIMP1 has been 
reported to bind arginyl-tRNA synthetase (RARS) and AIMP2 though the N-terminal coiled-
coil motif (15,16). When the first 70 a.a. of AIMP1 were tested for interaction with AIMP3, 
it was evident that the coiled-coil region is not sufficient to bind AIMP3 (Fig. 2D), although 
previous studies found that the first 70 a.a. of AIMP1 is sufficient to maintain robust RARS 
binding (16). These findings suggest that rather the entirety of AIMP1 with an intact intra-
molecular N- to C-terminus bond (9) was required for efficient AIMP3 binding. We 
hypothesize that the interaction site for AIMP3 is formed due to this intramolecular 
interaction within AIMP1. Lastly surface plasmon resonance (SPR) was utilized as an 
independent evaluation of AIMP1-AIMP3 interaction (Fig. 2E, F). Histidine-tagged AIMP1 
and AIMP3 were purified from bacterial lysates by metal-chelating chromatography. As 
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AIMP1 protein is more than twice the molecular weight than AIMP3, it was immobilized on 
the chip and AIMP3 was used as ligand. As shown in Fig. 2F at both a low and high 
concentration, AIMP3 interaction exhibits reversible binding to AIMP1 with an SPR 
Equilibrium Binding Constant (Kd) of 25.3 ± 1.13×10−13 nM.
DISCUSSION
Translation is an energy-costly process with two high-energy phosphate bond used in each 
of the three steps - aminoacyl-tRNA coupling, trans-peptidase activity and ribosomal 
translocation. Adaptation for more efficient and potentially co-regulated aa-tRNA coupling 
by ARS enzymes was necessary for mammalian eukaryotes compared to simpler Archaea. 
AIMP1/Arc1p is the only scaffold protein shared by eukaryotes, and there are no scaffolds in 
minimal prokaryotic and archaeic complexes (14). Instead of a GST-L domain found in 
Arc1p, the AIMP1 N-terminus contains a coiled-coil motif. All previously reported 
interactions for AIMP1 were mapped to this coiled-coil region (9). In addition, we 
previously reported intra-molecular bond within the AIMP1 protein (9). Here we report the 
observation of AIMP1 binding to AIMP3 in addition to independently reported AIMP1 and 
AIMP2 interaction (15).
Importantly, AIMP1 lacks a GST-L domain. However interaction of MARS, EPRS and a 
protein scaffold through their GST-L domain appears to be highly conserved. AIMP3 may 
function as a duplication of the EPRS N-terminal GST-L domain, rather than being derived 
from Arc1p (based on sequence similarity). Furthermore, as the Arc1P-GluRS-MetRS 
complex in yeast synchronizes nuclear transcription and mitochondrial translation of ATP 
synthetase genes (8), AIMP1 binding of EPRS, MARS, and the GST-L scaffold proteins 
AIMP2 and AIMP3 could facilitate a similar function in mammalian cells. This points to a 
tantalizing possibility for the emergence of MARS-scaffold-EPRS complex twice in the 
evolution of eukaryotes. Leading to the proposition that binding of AIMP1 to AIMP3 is the 
structural mammalian analogue to Arc1p, so that two polypeptides have the same function as 
the single polypeptide in yeast. This observation leads us to believe that methionine/glutamic 
acid ratio that reported to affect yeast longevity (6), might have similar significance in 
mammalian cells.
MATERIALS AND METHODS
cDNA constructs, cell culture and immuno-precipitation
HEK293 cells (ATCC) were cultured in DMEM supplemented with 10% FBS (Hyclone), 1x 
GlutaMax and penicillin and streptomycin. Transfections using TransIT-293 reagent 
(Mirrus). Immuno-precipitations (IP) with anti-eGFP llama single chain antibodies beads 
were performed as per manufacturer’s protocol (GFP-nAb™ Agarose, Allele). Equal protein 
amounts were utilized for western blotting of whole cell lysate and equal protein amounts 
were utilized for IP experiments. For IP and Western Blotting (WB) antibodies: anti- c-myc, 
anti-EGFP and C-terminal EPRS antibodies (Santa Cruz, sc-40, sc-9996 and sc-393505 
respectively), AIMP1 antibody (sc-376019), N-terminal specific anti-EPRS and anti-HA-
epitope (Bethyl, A303-957 and A190-108).
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AIMP1- EGFP and AIMP1- EGFP a.a. 1-70 expression constructs were described 
previously (9). Sequence of the primers and restriction sites are listed in Supplemental Table 
1S. AIMP1: a.a. 71-312 deletion mutant was cloned in-frame to pEGFP-N3 vector 
(Clontech). cDNA of AIMP3 ORF (PCR on MGC clone, Dharmacon, 
MHS6278-202839379), was cloned into pET-28a sites. Constructs for bacterial expression 
of GST-AIMP1 and GST-AIMP1 a.a. 1-70 fusions were described previously (9).
Myc-tagged deletion mutants of EPRS (EPRS a.a.1-200; EPRS a.a.1-70; EPRS a.a. 71-200 
and EPRS a.a. 31-200) were cloned into pCMV-MYC-N vector (Clontech) of the PCR 
products with MGC clone 4997672 (Dharmacon MHS1010-202697793) as template. Myc-
tagged EPRS a.a. 1-163 was made be excising KpnI-NotI fragment from EPRS a.a. 1-200 
construct. EPRS a.a. 1-410 and EPRS a.a. 1-657 were made by removing HindIII and 
BamHI fragments, respectively, from MCG clone 4997672, which by itself corresponds to 
EPRS a.a. 1-970.
AIMP2 constructs for mammalian and bacterial expression were produced by PCR on 
AIMP2 cDNA (Dharmacon MHS6278-202755556) and cloned into pCMV-HA-N 
(Clontech) at XhoI and NotI restriction sites, and re-cloned into pGEX4-3 using SalI and 
Not I for the fragment’s excision.
In vitro binding assay
GST- and His-tagged proteins were produced as described as previously described (9). GST 
fusion proteins bound to Glutathione Agarose beads equilibrated and His-tagged AIMP3 
eluted with 300mM imidazole in PBS and dialyzed. Agarose beads with bound recombinant 
GST- fusion proteins were incubated with His-tagged AIMP3 in PBS, 0.01% NP-40 at 4°C. 
Bound proteins were eluted in 1X Sample Buffer. The samples were resolved on 4–12% 
gradient gel (Invitrogen) and probed with anti AIMP3 antibodies (Santa Cruz Biotechnology 
sc-376019)
Mass-spectroscopy
Mass spectrometry was performed after in-gel tryptic digest using Matrix Assisted Laser 
Desorption Ionization-time of flight (MALDI-TOF) mass spectroscopy analysis at the 
University of Notre Dame Mass-spectroscopy and Proteomic facility.
Surface Plasmon Resonance
GST-AIMP1 protein immobilized on MC5 chip (manufacturer’s guidelines, GE Life 
Sciences). Amine coupling by covalently binding amine-containing substances to the sensor 
chip using 60 μL 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) 
with 60 μL of N-hydroxysuccinimide (NHS) and 90μL of the mixture was injected into the 
biacore machine. The AIMP1 protein was diluted (10mM sodium acetate buffer, pH 5.0, 
concentration 200 μg/mL) with 90 μL of 200 μg/mL AIMP1 injected into the machine. 1.0M 
ethanolamine-HCl, pH 8.5 was injected for chip deactivation. The AIMP3 protein was 
diluted to obtain a 200 μg/mL concentration (high concentration solution). Dilution of the 
concentrated AIMP3 solution ten fold gave the low concentration of AIMP3 (20 μg/mL). 
Low concentration of AIMP3 was injected followed by regeneration solution 50 mM NaOH. 
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A second injection of high concentration of AIMP3 was injected followed by regeneration 
solution. Using BIAevaluation software, the Δresonance Unit (ΔRU) was quantified and the 
point of saturation on the curve was noted to obtain a saturation profile. Using the 
KaleidaGraph software and the plotted protein concentration, the ΔRU responses were 
determined and appeared on the graph as the apparent Kd of the interaction.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbreviations
EMAP II Endothelial-Monocyte Activating Polypeptide II
AIMP aminoacyl tRNA synthetase complex interacting multifunctional protein
aa amino acids
MSC multi-synthetase complex
ARS aa-tRNA synthetases
Arc1p ARS cofactor 1 protein
MARS Methionyl-tRNA synthetase
EPRS Glutamyl-Prolyl-tRNA Synthetase
RARS Arginyl-tRNA Synthetase
GST-L GST-like
TRBD tRNA (TR) binding domain
MALDI-TOFMatrix Assisted Laser Desorption Ionization-time of flight
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Highlights
• AIMP1 binds the N-terminal GST-like domain of the ARS protein EPRS
• AIMP1 binds the GST-like domain of the MSC scaffold protein AIMP3
• Binding of full-length AIMP1 to AIMP2 enhances AIMP1-EPRS binding
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FIGURE 1. AIMP1 a.a. 1-312 co-precipitates with the MSC complex protein EPRS whose GST-
like domain is sufficient for AIMP1 interaction
HEK293 cells transfected (A) with (1) AIMP1- EGFP fusion (2) pEGFP-N3 vector (3) 
AIMP1- EGFP a.a. 146-312. Silver staining of protein immuno-precipitated with anti-EGFP 
llama antibodies identified a unique p175 band (lane 1, arrow) identified as EPRS (11unique 
peptides, MALDI-TOF) (endogenous AIMP1 IP sent for MS confirmed EPRS co-
precipitation data not shown, n=3). HEK293 cells transfected with EPRS1-970 truncated (t) 
aa protein (B) and EGFP fusions as indicated: AIMP1 a.a. 1-312, pEGFP-N3 vector, and 
AIMP1- EGFP a.a. 146-312 were examined for binding to EPRS. Input analysis determined 
equal transfection (whole cell lysates:WCL, anti-GFP antibody). IP for αEGFP probed for 
C-terminus EPRS or N-terminus EPRS antibodies (B, Output Arrows) determined that full 
length AIMP1 (a.a.1-312) co-precipitated with EPRS while the truncated C-terminus of 
AIMP1 (a.a. 146-312) and empty N3 Vector did not. Schematic representation of EPRS 
domain architecture: GST-like domain, Glu-ARS, WHEP domain, and a Pro-ARS domain 
(C). Deletion analysis of EPRS and AIMP1 using myc tagged EPRS deletion mutants with 
AIMP1- EGFP a.a. 312 EGFP fusion protein (all samples). Co-IP with EGFP and WB myc 
and input analysis confirmed expression of deletion construct and fusion protein expression 
(D). Pull down of myc-EPRS deletion mutants with myc IP and endogenous AIMP1 WB 
endogenous (E). Summary of the EPRS deletion mutants co-IP with AIMP1- EGFP: “+” 
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designating interaction with AIMP1, “−” indicating no interaction. WHEP repeat domains 
are near the C-terminal residue 657 (F).
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FIGURE 2. AIMP2 associates with AIMP1 binding to EPRS, while full length AIMP1 a.a. 1-312 
binds AIMP3
AIMP1- EGFP a.a. 1-70 fusion protein transiently expressed in HEK293 cell line with myc-
EPRS a.a. 1-200 and HA-AIMP2. Validation of transfection efficiency determined by input 
analysis with WB of EGFP and myc antibodies (A). Co-immunoprecipitation with EGFP 
and WB analysis of myc and HA (Output). Immuno-precipitation of overexpressed EGFP-
N3 vector, AIMP1- EGFP a.a. 1-70 or AIMP1- EGFP a.a. 1-212 was probed for endogenous 
EPRS and AIMP3 (B). Input and output analysis of GFP confirmed expression. In vitro 
AIMP1 and AIMP3 interaction used purified recombintant His-tagged AIMP3, GST-control, 
GST-tagged AIMP1 and GST-tagged AIMP1 a.a. 1-70 purified from bacterial lysates (C). 
AIMP3 was eluted from nickel beads, while GST fusions left bound to glutathione beads 
used for pull down. WB analysis was performed using an AIMP3 antibody (D). Surface 
plasmon resonance using histidine-tagged AIMP1 and AIMP3 purified from bacterial 
lysates. AIMP1 was immobilized on the chip and AIMP3 was used as a ligand at low 
concentration (10 fold dilute, 20 μg/mL, Blue line: E) and high concentration (Red line: E, 
200 μg/mL) (n=5, representative) with reversible binding demonstrated and an SPR 
Equilibrium Binding Constant of 25.325 ±01.13×10−13 SD Kd (nM) determined using 
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equilibrium constants where injection of AIMP3 where each point represents a saturation 
point on the sensogram. Kd values were determined by fitting ≥ 5 points with a nonlinear 
least squares analysis of the binding isotherm (Req=Rmax/(1+Kd/C). E, is a representative 
sensogram from the data showing AIMP1/AIMP3 binding responses over time. Equilibrium 
binding curves of AIMP1/AIMP3 at given concentrations and Kd values determined from an 
average of 3 separate experiments ± SD (F).
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Table 1
MALDI-TOF Mass-Spectroscopy of excised 175 kDa band from AIMP1 Immunoprecipitation (Fig. 1A).
Sequence # PSMs Protein Group Accessions
SLYDEVAAQGEVVR 1 Bifunctional aminoacyl-tRNA synthetase OS=Homo sapiens GN=EPRS PE=1 SV=4 - 
[SYEP_HUMAN]
DQVDIAVQELLQLK 1 Bifunctional aminoacyl-tRNA synthetase OS=Homo sapiens GN=EPRS PE=1 SV=4 - 
[SYEP_HUMAN]
MFEIVFEDPK 1 Bifunctional aminoacyl-tRNA synthetase OS=Homo sapiens GN=EPRS PE=1 SV=4 - 
[SYEP_HUMAN]
FAGGDYTTTIEAFISASGR 1 Bifunctional aminoacyl-tRNA synthetase OS=Homo sapiens GN=EPRS PE=1 SV=4 - 
[SYEP_HUMAN]
EENLADWYSQVITK 1 Bifunctional aminoacyl-tRNA synthetase OS=Homo sapiens GN=EPRS PE=1 SV=4 - 
[SYEP_HUMAN]
WFGFLEAQQAFQSVGTK 1 Bifunctional aminoacyl-tRNA synthetase OS=Homo sapiens GN=EPRS PE=1 SV=4 - 
[SYEP_HUMAN]
mFEIVFEDPK 1 Bifunctional aminoacyl-tRNA synthetase OS=Homo sapiens GN=EPRS PE=1 SV=4 - 
[SYEP_HUMAN]
QFAYQnSWGLTTR 3 Bifunctional aminoacyl-tRNA synthetase OS=Homo sapiens GN=EPRS PE=1 SV=4 - 
[SYEP_HUMAN]
LNLNNTVLSK 2 Bifunctional aminoacyl-tRNA synthetase OS=Homo sapiens GN=EPRS PE=1 SV=4 - 
[SYEP_HUMAN]
VAVQGDVVR 1 Bifunctional aminoacyl-tRNA synthetase OS=Homo sapiens GN=EPRS PE=1 SV=4 - 
[SYEP_HUMAN]
EVIPVNVPEAQEEmK 1 Bifunctional aminoacyl-tRNA synthetase OS=Homo sapiens GN=EPRS PE=1 SV=4 - 
[SYEP_HUMAN]
AYVDDTPAEQMK 1 Bifunctional aminoacyl-tRNA synthetase OS=Homo sapiens GN=EPRS PE=1 SV=4 - 
[SYEP_HUMAN]
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